Back to Clinical Trials
N/ARecruiting

Working Memory Training in Patients with Mild Cognitive Impairment

Sponsored by St. Joseph's Hospital and Medical Center, Phoenix

About this study

The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).

The goal of this study is to conduct a pilot clinical trial aimed at comparing the effects of CogMed intervention plus Treatment As Usual (TAU) versus TAU alone in patients with Mild Cognitive Impairment (MCI). Based on our preliminary data from brain health program, the primary hypothesis is that the CogMed intervention may improve the CogMed measures and possibly working memory. This may improve sense of self-efficacy and lead to a decrease in perceived stress, thereby demonstrating possible transfer of cognitive benefits to biobehavioral construct of perceived stress. Additionally, the study aims to demonstrate the feasibility of collecting p-Tau 217, a blood based Alzheimer's Disease biomarker, from MCI patients. Though no significant changes in pTau 217 are expected due to the short d…

Where this study is enrolling

  • Barrow Neurological Institute, Division of Alzheimer's Disease

    Phoenix, Arizona

    I'm interested
Who can participate

Inclusion criteria

  • ✓1. Male or female outpatients ages ≥ 50 years;
  • ✓2. Meet Mayo Clinic Criteria for MCI. (Patients with mild cognitive impairment)
  • ✓3. Access to the internet through computer
  • ✓4. A proficiency in speaking and reading English or having a family member who is proficient in reading and speaking English and is willing to serve as a translator.
  • ✓5. Vision and hearing must be sufficient to comply with study procedures.

Exclusion criteria

  • ✕1. Mini Mental State Exam (MMSE) score less than 19 or patients diagnosed with moderate or severe dementia by a clinician.
  • ✕2. In the opinion of the investigator, participation would not be in the best interest of the subject.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.